January 9, 2017 08:16 AM ESTUpdated 09:48 AM
Deals

Take­da grabs Ari­ad, ex­pands on­col­o­gy port­fo­lio in $5.2B buy­out

John Carroll

Editor & Founder

Take­da has tak­en the next step in its glob­al re­struc­tur­ing, bag­ging Ari­ad Phar­ma­ceu­ti­cals for $5.2 bil­lion and pay­ing a whop­ping 74% pre­mi­um for its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times